PortfoliosLab logoPortfoliosLab logo
FISV vs. BSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FISV vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fiserv, Inc (FISV) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FISV achieves a -19.93% return, which is significantly higher than BSX's -50.80% return. Over the past 10 years, FISV has underperformed BSX with an annualized return of 0.17%, while BSX has yielded a comparatively higher 7.42% annualized return.


FISV

1D
1.36%
1M
2.69%
YTD
-19.93%
6M
-21.77%
1Y
-67.99%
3Y*
-23.21%
5Y*
-13.37%
10Y*
0.17%

BSX

1D
-0.55%
1M
-11.59%
YTD
-50.80%
6M
-49.33%
1Y
-52.40%
3Y*
-2.85%
5Y*
1.80%
10Y*
7.42%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FISV vs. BSX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FISV
Fiserv, Inc
-19.93%-67.30%54.64%31.43%-2.62%-8.84%-1.53%57.34%12.09%23.38%
BSX
Boston Scientific Corporation
-50.80%6.75%54.51%24.94%8.92%18.16%-20.50%27.96%42.56%14.61%

Correlation

The correlation between FISV and BSX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.34

Correlation (5Y)
Calculated over the trailing 5-year period

0.42

Correlation (10Y)
Calculated over the trailing 10-year period

0.45

Correlation (All Time)
Calculated using the full available price history since May 19, 1992

0.30

The correlation between FISV and BSX shifts across timeframes, from 0.27 (1 year) to 0.45 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FISV:

$28.79B

BSX:

$70.13B

EPS

FISV:

$5.91

BSX:

$2.38

PE Ratio

FISV:

9.10

BSX:

19.74

PEG Ratio

FISV:

0.25

BSX:

0.44

PS Ratio

FISV:

1.38

BSX:

3.40

PB Ratio

FISV:

1.10

BSX:

2.71

Total Revenue (TTM)

FISV:

$21.09B

BSX:

$20.62B

Gross Profit (TTM)

FISV:

$9.52B

BSX:

$14.52B

EBITDA (TTM)

FISV:

$7.75B

BSX:

$4.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FISV vs. BSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FISV
FISV Risk / Return Rank: 55
Overall Rank
FISV Sharpe Ratio Rank: 22
Sharpe Ratio Rank
FISV Sortino Ratio Rank: 44
Sortino Ratio Rank
FISV Omega Ratio Rank: 11
Omega Ratio Rank
FISV Calmar Ratio Rank: 33
Calmar Ratio Rank
FISV Martin Ratio Rank: 1313
Martin Ratio Rank

BSX
BSX Risk / Return Rank: 22
Overall Rank
BSX Sharpe Ratio Rank: 00
Sharpe Ratio Rank
BSX Sortino Ratio Rank: 22
Sortino Ratio Rank
BSX Omega Ratio Rank: 11
Omega Ratio Rank
BSX Calmar Ratio Rank: 55
Calmar Ratio Rank
BSX Martin Ratio Rank: 11
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FISV vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fiserv, Inc (FISV) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FISVBSXDifference
Sharpe ratioReturn per unit of total volatility

+0.29

Sortino ratioReturn per unit of downside risk

+0.48

Omega ratioGain probability vs. loss probability

0.64

0.67

-0.02

Calmar ratioReturn relative to maximum drawdown

-0.97

-0.93

-0.04

Martin ratioReturn relative to average drawdown

-1.29

-2.00

+0.71

FISV vs. BSX - Sharpe Ratio Comparison

The current FISV Sharpe Ratio is -1.22, which is comparable to the BSX Sharpe Ratio of -1.51. The chart below compares the historical Sharpe Ratios of FISV and BSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FISV vs. BSX - Drawdown Comparison

The maximum FISV drawdown since its inception was -77.98%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for FISV and BSX.


Loading charts...

Drawdown Indicators


FISVBSXDifference

Max Drawdown

Largest peak-to-trough decline

-77.98%

-89.15%

+11.17%

Max Drawdown (1Y)

Largest decline over 1 year

-70.17%

-56.62%

-13.55%

Max Drawdown (3Y)

Largest decline over 3 years

-77.98%

-56.62%

-21.36%

Max Drawdown (5Y)

Largest decline over 5 years

-77.98%

-56.62%

-21.36%

Max Drawdown (10Y)

Largest decline over 10 years

-77.98%

-56.62%

-21.36%

Current Drawdown

Current decline from peak

-77.38%

-56.62%

-20.76%

Average Drawdown

Average peak-to-trough decline

-11.18%

-38.76%

+27.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

52.85%

26.23%

+26.62%

Volatility

FISV vs. BSX - Volatility Comparison

The current volatility for Fiserv, Inc (FISV) is 11.15%, while Boston Scientific Corporation (BSX) has a volatility of 15.84%. This indicates that FISV experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FISVBSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.15%

15.84%

-4.69%

Volatility (6M)

Calculated over the trailing 6-month period

26.49%

32.83%

-6.34%

Volatility (1Y)

Calculated over the trailing 1-year period

55.98%

34.77%

+21.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.61%

25.69%

+9.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.62%

27.29%

+4.33%

Dividends

FISV vs. BSX - Dividend Comparison

Neither FISV nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FISV vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Fiserv, Inc and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


3.00B3.50B4.00B4.50B5.00B5.50B20222023202420252026
5.03B
5.20B
(FISV) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

FISV vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Fiserv, Inc and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
69.4%
Portfolio components
FISV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fiserv, Inc reported a gross profit of 0.00 and revenue of 5.03B. Therefore, the gross margin over that period was 0.0%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.

FISV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fiserv, Inc reported an operating income of 918.00M and revenue of 5.03B, resulting in an operating margin of 18.3%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.

FISV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fiserv, Inc reported a net income of 571.00M and revenue of 5.03B, resulting in a net margin of 11.4%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.


Frequently Asked Questions


FISV and BSX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BSX has higher volatility (15.84%) compared to FISV (11.15%). In terms of maximum drawdown, FISV dropped -77.98% vs BSX's -89.15%.

FISV currently has the higher Sharpe Ratio (-1.22 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FISV and BSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer